Skip to main content
. Author manuscript; available in PMC: 2012 Sep 23.
Published in final edited form as: Neuropharmacology. 2009 Jan 21;56(5):886–895. doi: 10.1016/j.neuropharm.2009.01.013

Figure 7.

Figure 7

Pretreatment with a GABAB agonist reduces EtOH potentiation of sIPSC frequency. Top, sIPSCs recorded from a representative cell during 1 μM baclofen pretreatment and during baclofen + EtOH conditions. Bottom, bar graph summarizing the effect of EtOH alone and following pretreatment with 1 μM baclofen on sIPSC frequency, amplitude, and decay. Numbers in parentheses represent the number of cells tested under each experimental condition.*, significant difference from control conditions (p < 0.05). #, significant difference between groups (p < 0.05).